Request for Covid-19 Impact Assessment of this Report
Market Segmentation:
By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Country (South Africa, South Arabia, UAE, Kuwait, Rest of Middle East & Africa)
Some of the major factor contributing to the growth of the market is:
• Growth opportunities in developing countries
Market Players:
The key market players for Middle East and Africa drug safety solutions and pharmacovigilance market are listed below:
• Pharmaceutical Product Development, LLC
• Drug Safety Solutions Limited
• C3i
• Worldwide Clinical Trials
• Bioclinica
• United Biosource LLC
• Ennov
• AB Cube
• Covance Inc.
• Accenture
• PRA Health Sciences, Inc.
• Ergomed
• IQVIA
• Genpact
• Cognizant
• Parexel International Corporation
• ArisGlobal
• ICON plc
• Oracle
• Syneos Health
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING NUMBER OF CLINICAL TRIALS
3.1.2 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS
3.1.3 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
3.1.4 INCREASE IN THE NUMBER OF ADVERSE DRUG REACTIONS (ADRS)
3.2 RESTRAINT
3.2.1 HIGH COST OF DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE
3.3 OPPORTUNITIES
3.3.1 AUTOMATION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE
3.3.2 RESEARCH COLLABORATIONS AND PARTNERSHIPS
3.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
3.4 CHALLENGE
3.4.1 THE MISREPORTING AND MISCODING OF ADVERSE EVENTS
4 EXECUTIVE SUMMARY
5 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE
5.1 OVERVIEW
5.2 SOFTWARE
5.2.1 ADVERSE EVENT REPORTING SOFTWARE
5.2.1.1 ON-PREMISE
5.2.1.2 CLOUD BASED
5.2.2 DRUG SAFETY AUDITS SOFTWARE
5.2.2.1 ON-PREMISE
5.2.2.2 CLOUD BASED
5.2.3 DATA MANAGEMENT SOFTWARE
5.2.3.1 ON-PREMISE
5.2.3.2 CLOUD BASED
5.2.4 FULLY INTEGRATED SOFTWARE
5.2.4.1 ON-PREMISE
5.2.4.2 CLOUD BASED
5.2.5 ISSUE TRACKING SOFTWARE
5.2.5.1 ON-PREMISE
5.2.5.2 CLOUD BASED
5.2.6 CLINICAL TRIAL MANAGEMENT SOLUTION
5.2.6.1 ON-PREMISE
5.2.6.2 CLOUD BASED
5.2.7 REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE
5.2.7.1 ON-PREMISE
5.2.7.2 CLOUD BASED
5.2.8 MEDICAL AFFAIRS SOFTWARE
5.2.8.1 ON-PREMISE
5.2.8.2 CLOUD BASED
5.2.9 OTHERS
5.2.9.1 ON-PREMISE
5.2.9.2 CLOUD BASED
5.3 SERVICES
5.3.1 CLINICAL DATA MANAGEMENT
5.3.1.1 DATA ENTRY AND CASE PROCESSING
5.3.1.2 CLINICAL TRIAL MONITORING
5.3.1.3 CLINICAL TRIAL SAFETY SUBMISSIONS
5.3.1.4 CASE PROCESSING (SAES)
5.3.1.5 OTHERS
5.3.2 DRUG SAFETY SOLUTIONS
5.3.2.1 QUALITY AND MEDICAL REVIEW
5.3.2.2 LITERATURE AND SOCIAL MEDIA MONITORING
5.3.2.3 SAFETY DATABASE
5.3.2.4 INDIVIDUAL CASE STUDY REPORT
5.3.2.5 PERIODIC REPORTS
5.3.2.6 MEDICAL LITERATURE SEARCH
5.3.2.7 SIGNAL DETECTION
5.3.2.8 EXPEDITED REPORTS
5.3.2.9 OTHERS
5.3.3 AGGREGATE SAFETY REPORTING
5.3.4 REGULATORY SERVICES
5.3.4.1 SAFETY REGULATORY SUBMISSIONS
5.3.4.2 POST-MARKETING SURVEILLANCE
5.3.4.3 MEDICAL DEVICE VIGILANCE
5.3.4.4 REGULATORY CONSULTING
5.3.4.5 OTHERS
5.3.5 RISK MANAGEMENT SERVICES
5.3.6 MEDICAL INFORMATION CALL CENTER SERVICES
5.3.7 AUDIT SERVICES
5.3.8 TRAINING SUPPORT SERVICES
5.3.9 OTHERS
6 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USERS
6.1 OVERVIEW
6.2 PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES
6.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
6.4 HOSPITALS
6.5 KPOS/BPOS
6.6 HEALTHCARE PROVIDERS
6.7 OTHERS
7 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW
7.2 DIRECT SALES
7.3 RETAIL SALES
8 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY GEOGRAPHY
8.1 MIDDLE EAST AND AFRICA
8.1.1 UAE
8.1.2 SAUDI ARABIA
8.1.3 KUWAIT
8.1.4 SOUTH AFRICA
8.1.5 REST OF MIDDLE EAST AND AFRICA
9 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
10 COMPANY PROFILE
10.1 SYNEOS HEALTH
10.1.1 COMPANY SNAPSHOT
10.1.2 REVENUE ANALYSIS
10.1.3 COMPANY SHARE ANALYSIS
10.1.4 SOLUTION PORTFOLIO
10.1.5 RECENT DEVELOPMENT
10.2 COVANCE INC. (A SUBSIDIARY OF LABCORP)
10.2.1 COMPANY SNAPSHOT
10.2.2 REVENUE ANALYSIS
10.2.3 COMPANY SHARE ANALYSIS
10.2.4 SERVICE PORTFOLIO
10.2.5 RECENT DEVELOPMENTS
10.3 COGNIZANT
10.3.1 COMPANY SNAPSHOT
10.3.2 REVENUE ANALYSIS
10.3.3 COMPANY SHARE ANALYSIS
10.3.4 SOLUTION PORTFOLIO
10.3.5 RECENT DEVELOPMENT
10.4 ACCENTURE
10.4.1 COMPANY SNAPSHOT
10.4.2 REVENUE ANALYSIS
10.4.3 COMPANY SHARE ANALYSIS
10.4.4 SERVICE PORTFOLIO
10.4.5 RECENT DEVELOPMENTS
10.5 PAREXEL INTERNATIONAL CORPORATION
10.5.1 COMPANY SNAPSHOT
10.5.2 PRODUCT PORTFOLIO
10.5.3 RECENT DEVELOPMENTS
10.6 ORACLE
10.6.1 COMPANY SNAPSHOT
10.6.2 REVENUE ANALYSIS
10.6.3 SOLUTION PORTFOLIO
10.6.4 RECENT DEVELOPMENT
10.7 AB CUBE
10.7.1 COMPANY SNAPSHOT
10.7.2 SOLUTION PORTFOLIO
10.7.3 RECENT DEVELOPMENT
10.8 ARISMIDDLE EAST AND AFRICA
10.8.1 COMPANY SNAPSHOT
10.8.2 PRODUCT PORTFOLIO
10.8.3 RECENT DEVELOPMENTS
10.9 BIOCLINICA
10.9.1 COMPANY SNAPSHOT
10.9.2 SERVICE PORTFOLIO
10.9.3 RECENT DEVELOPMENTS
10.10 C3I
10.10.1 COMPANY SNAPSHOT
10.10.2 REVENUE ANALYSIS
10.10.3 SERVICE PORTFOLIO
10.10.4 RECENT DEVELOPMENTS
10.11 DRUG SAFETY SOLUTIONS LIMITED
10.11.1 COMPANY SNAPSHOT
10.11.2 SERVICE PORTFOLIO
10.11.3 RECENT DEVELOPMENT
10.12 ENNOV
10.12.1 COMPANY SNAPSHOT
10.12.2 PRODUCT PORTFOLIO
10.12.3 RECENT DEVELOPMENTS
10.13 ERGOMED PLC
10.13.1 COMPANY SNAPSHOT
10.13.2 REVENUE ANALYSIS
10.13.3 SERVICE PORTFOLIO
10.13.4 RECENT DEVELOPMENTS
10.14 GENPACT
10.14.1 COMPANY SNAPSHOT
10.14.2 REVENUE ANALYSIS
10.14.3 PRODUCT PORTFOLIO
10.14.4 RECENT DEVELOPMENTS
10.15 ICON PLC
10.15.1 COMPANY SNAPSHOT
10.15.2 REVENUE ANALYSIS
10.15.3 SERVICE PORTFOLIO
10.15.4 RECENT DEVELOPMENTS
10.16 IQVIA
10.16.1 COMPANY SNAPSHOT
10.16.2 REVENUE ANALYSIS
10.16.3 SOLUTION PORTFOLIO
10.16.4 RECENT DEVELOPMENTS
10.17 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
10.17.1 COMPANY SNAPSHOT
10.17.2 SERVICE PORTFOLIO
10.17.3 RECENT DEVELOPMENTS
10.18 PHARMACEUTICAL RESEARCH ASSOCIATES INC.
10.18.1 COMPANY SNAPSHOT
10.18.2 REVENUE ANALYSIS
10.18.3 SOLUTION PORTFOLIO
10.18.4 RECENT DEVELOPMENTS
10.19 UNITED BIOSOURCE LLC
10.19.1 COMPANY SNAPSHOT
10.19.2 SERVICE PORTFOLIO
10.19.3 RECENT DEVELOPMENT
10.20 WORLDWIDE CLINICAL TRIALS
10.20.1 COMPANY SNAPSHOT
10.20.2 SERVICE PORTFOLIO
10.20.3 RECENT DEVELOPMENTS
11 QUESTIONNAIRE
12 RELATED REPORTS
UU
TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS
TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
TABLE 3 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY END USER, 2017-2026 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA HOSPITALS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA KPOS/BPOS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA HEALTHCARE PROVIDERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA DIRECT SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA RETAIL SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 57 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 58 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 59 UAE ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 60 UAE DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 61 UAE DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 62 UAE FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 63 UAE ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 64 UAE CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 65 UAE REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 66 UAE MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 67 UAE OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 68 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 69 UAE CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 70 UAE DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 71 UAE REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 72 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 73 UAE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 74 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 75 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 76 SAUDI ARABIA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 77 SAUDI ARABIA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 78 SAUDI ARABIA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 79 SAUDI ARABIA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 80 SAUDI ARABIA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 81 SAUDI ARABIA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 82 SAUDI ARABIA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 83 SAUDI ARABIA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 84 SAUDI ARABIA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 85 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 86 SAUDI ARABIA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 87 SAUDI ARABIA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 88 SAUDI ARABIA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 89 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 90 SAUDI ARABIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 91 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 92 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 93 KUWAIT ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 94 KUWAIT DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 95 KUWAIT DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 96 KUWAIT FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 97 KUWAIT ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 98 KUWAIT CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 99 KUWAIT REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 100 KUWAIT MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 101 KUWAIT OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 102 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 103 KUWAIT CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 104 KUWAIT DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 105 KUWAIT REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 106 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 107 KUWAIT DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 108 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 109 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 110 SOUTH AFRICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 111 SOUTH AFRICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 112 SOUTH AFRICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 113 SOUTH AFRICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 114 SOUTH AFRICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 115 SOUTH AFRICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 116 SOUTH AFRICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 117 SOUTH AFRICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 118 SOUTH AFRICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 119 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 120 SOUTH AFRICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 121 SOUTH AFRICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 122 SOUTH AFRICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 123 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 124 SOUTH AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 125 REST OF MIDDLE EAST AND AFRICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...